Skip to main content

Find Clinical Trials

Home
Conditions
Wegener's Granulomatosis

Clinical trial condition

Wegener's Granulomatosis

Explore clinical trials studying Wegener's Granulomatosis. Study availability and eligibility vary by location and protocol.

27 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Wegener's Granulomatosis trial results

Completed

Anti-Cytokine Therapy for Vasculitis

NCT00753103

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +19 more
Locations: University Hospitals Birmingham NHS Foundation Trust Birmingham, West Midlands, United Kingdom

View Trial Details

Completed

Steroids and Methotrexate to Treat Systemic Vasculitis

NCT00001256

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +23 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Etanercept to Treat Wegener's Granulomatosis

NCT00001901

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis

NCT00001541

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +15 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

NCT00001473

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +16 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Daclizumab to Treat Wegener's Granulomatosis

NCT00040248

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +16 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

NCT00072592

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography

NCT00001759

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +18 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Treatment of Wegener's Granulomatosis With Cyclophosphamide

NCT00001155

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +18 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis

NCT00001761

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +15 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details